FDA Approves Generic Lenacapavir for HIV, but Brazil Is Left Out of Cheap Distribution
The highly effective twice-yearly injection will reach 120 countries at US$ 40 per person per year; in Brazil, the maximum authorized price is R$ 20,900 per dose.
Health
Public health, medicine and wellbeing.
10 storiesChild Dies of Measles in New York as US Reaches Six Deaths in 2026
The state records its first death from the disease in more than 30 years; the country has 4,852 cases this year, double the 2025 total.
Study Projects 39% Rise in Cervical Cancer Deaths Worldwide by 2050
Research in Nature Medicine analyzed 204 countries; for Brazil, the estimate points to 26,500 cases and 10,900 deaths in 2023.
Nov 01 · 23:00
Obesity Care in SUS Primary Care Grows 259% in Ten Years
Sisvan records 11.12 million adults with obesity in 2026; 71.5% of those monitored are above their ideal weight.
Nov 01 · 17:26
Mpox Cases in Rio State Already Exceed 2025 Total
State Health Department confirms 211 cases in 2026, compared with 119 last year, with no deaths recorded; the capital accounts for 167.
Nov 01 · 05:00
Daily Pill for Lung Cancer Keeps 55% of Patients Free of Progression After Seven Years
The result with lorlatinib is unprecedented in advanced disease, but the drug costs about R$ 37,000 a month and is not covered by the SUS.
Oct 31 · 08:05
Transplant Waiting List Reaches 49,700 People in Brazil, With Kidneys Leading Demand
The family of a 14-year-old goalkeeper donated organs and helped bring the issue to light; São Paulo has 23,700 patients waiting.
Oct 31 · 06:11
Work Leaves for Gambling Addiction Hit Record in 2026 and Already Exceed All of Last Year
INSS granted 377 benefits for gambling disorder through August; experts say the real number is higher because of underreporting.
Oct 30 · 13:00
Only 1.5% of Municipalities Meet the Flu Vaccination Target
Health Ministry dashboard shows 52.45% coverage of the target group in the South, Southeast, Center-West and Northeast; experts cite El Niño.
Oct 29 · 04:00
Anvisa Approves Five More Pens for Diabetes and Obesity; Total Reaches 20 in 2026
The new registrations are for liraglutide and semaglutide, but there is still no launch date or set pharmacy price.